You are here

  • Home
  • Archive
  • Volume 27, Issue 5
  • Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

Article metrics

Article menu
Download PDFPDF
Short report
Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 201828924
Mar 2018306135
Apr 201816572
May 201818016
Jun 20188113
Jul 201818323
Aug 201810100
Sep 20185410
Oct 20187800
Nov 20184911
Dec 20187421
Jan 20197010
Feb 20196800
Mar 20192400
Apr 20193900
May 20193910
Jun 20192500
Jul 20195434
Aug 20194900
Sep 20194803
Oct 20199810
Nov 20195811
Dec 20195800
Jan 202015132
Feb 20209801
Mar 20206900
Apr 20203310
May 20204503
Jun 20202900
Jul 20203411
Aug 202021056
Sep 202027087
Oct 202012344
Nov 20209520
Dec 202011522
Jan 202113021
Feb 20215422
Mar 20215500
Apr 20213800
May 2021600
Aug 2021643
Sep 2021100
Oct 20214200
Nov 20213910
Dec 20214000
Jan 20222510
Feb 20225002
Mar 20227101
Apr 20228400
May 202216200
Jun 20227511
Jul 20227120
Aug 20225204
Sep 20226313
Oct 20229820
Nov 20224700
Dec 20223000
Jan 20234300
Feb 20239400
Mar 20234300
Apr 20231400
May 20232210
Jun 20233611
Jul 20231900
Aug 20231700
Sep 2023600
Oct 20231710
Nov 20232710
Dec 20231800
Jan 20243201
Feb 20245800
Mar 20244600
Total51938378